Why is Genesis IBRC India Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.64
- The company has been able to generate a Return on Equity (avg) of 9.30% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
- NO KEY NEGATIVE TRIGGERS
3
With ROE of 41.9, it has a Very Expensive valuation with a 19.2 Price to Book Value
- Over the past year, while the stock has generated a return of 603.43%, its profits have fallen by 0%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-1.28%
ROE (avg)
9.30%
Valuation Key Factors 
Factor
Value
P/E Ratio
125
Industry P/E
36
Price to Book Value
52.57
EV to EBIT
125.03
EV to EBITDA
125.03
EV to Capital Employed
53.06
EV to Sales
119.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
42.44%
ROE (Latest)
41.92%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend